Filing Flows › TScan Therapeutics (TCRX) › How it makes money
How TScan Therapeutics (TCRX) makes money
TScan Therapeutics (TCRX) made $1.1M of revenue in the second quarter 2026 (Q2 2026), -66% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $1.1M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $1.1M | -66% |
| Q1 2026 | $982K | -55% |
| Q4 2025 | $2.6M | +286% |
| Q3 2025 | $2.5M | +139% |
| Q2 2025 | $3.1M | +474% |
| Q1 2025 | $2.2M | +284% |
| Q4 2024 | $665K | -91% |
From TScan Therapeutics' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does TScan Therapeutics make money?
TScan Therapeutics (TCRX) made $1.1M of revenue in the second quarter 2026 (Q2 2026), -66% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.